Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Three genes in Arabidopsis are important for plant growth and development by affecting sugar attachment to proteins.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Gambogic Amide may prevent hair greying and promote hair growth by maintaining hair pigmentation.

SV40 T antigen in hair follicles causes abnormal hair and health issues in mice.

PEGylated thymosin β4 shows promise for treating heart attacks effectively.

Early genetic testing and JAK inhibitors can help treat systemic inflammation in SAVI patients.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Gingerol may help treat chronic graft-versus-host disease by improving immune cell balance.

Nitrate helps plants manage phosphate uptake and starvation responses through NIGT1 proteins.

A specific gene variation in goats is linked to better growth traits.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Topical GT20029 effectively promotes hair regrowth and is well-tolerated.

Dermal IgA deposition without symptoms is rare in Dermatitis herpetiformis risk groups.

Tigason improved hair growth in a boy with monilethrix without side effects.

Topical tofacitinib is effective in promoting hair growth for non-scarring alopecia.

The TGM3 gene's promoter region is key for skin and hair cell function and may aid gene therapy.

A man had two rare autoimmune diseases that might be connected.

Itraconazole is potentially effective for treating invasive aspergillosis, but more research is needed.

The treatment effectively promotes hair regrowth in androgenetic alopecia without causing skin irritation.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

Tofacitinib effectively improved severe skin symptoms in a patient with Hypohidrotic Ectodermal Dysplasia.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

PROTACs have become a breakthrough in medicine by effectively targeting and degrading specific proteins to treat diseases.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

SCD-153 shows promise as an effective topical treatment for alopecia areata.